Location History:
- Carrière-sur-Seine, FR (2006 - 2008)
- Carrleves sur Seine, FR (2017)
- Carrieres sur Seine, FR (2011 - 2020)
Company Filing History:
6 out of 870 
6 out of 1,744 
Years Active: 2006-2020
Title: Sylvain Cardinaud: Innovator in Anticancer Therapy
Introduction
Sylvain Cardinaud is a prominent inventor based in Carrieres sur Seine, France. He has made significant contributions to the field of anticancer therapy, holding a total of 6 patents. His work focuses on the identification and utilization of immunogenic peptides derived from human telomerase reverse transcriptase (hTERT).
Latest Patents
One of his latest patents involves polynucleotides encoding MHC class I-restricted hTERT epitopes and their analogues. This invention is crucial for advancing anticancer therapies. It encompasses the identification of immunogenic peptides that can be used in the treatment and prevention of cancer. The patent also includes vectors and cells that comprise these polynucleotides, as well as compositions containing hTERT polypeptides for therapeutic applications.
Career Highlights
Throughout his career, Sylvain Cardinaud has worked with esteemed institutions such as Institut Pasteur and the Institut National de la Santé et de la Recherche Médicale. His research has significantly impacted the development of innovative cancer treatments.
Collaborations
He has collaborated with notable colleagues, including Pierre Langlade-Demoyen and Francisco Garcia Pons. These partnerships have further enriched his research and contributions to the field.
Conclusion
Sylvain Cardinaud's innovative work in anticancer therapy exemplifies the importance of research and development in medical science. His patents and collaborations continue to pave the way for advancements in cancer treatment.